Curative Biotechnology, Inc.
CUBT
$0.01
$0.000.00%
OTC PK
| 09/30/2025 | 03/31/2025 | 09/30/2024 | 06/30/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -4.64M | -5.34M |
| Total Depreciation and Amortization | -- | -- | -- | 1.70K | 500.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | 285.80K | 6.30K |
| Total Other Non-Cash Items | -- | -- | -- | 790.10K | 3.18M |
| Change in Net Operating Assets | -- | -- | -- | 1.07M | 549.10K |
| Cash from Operations | -- | -- | -- | -2.49M | -1.60M |
| Capital Expenditure | -- | -- | -- | -6.80K | -6.80K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -46.70K | -14.50K |
| Cash from Investing | -- | -- | -- | -53.50K | -21.30K |
| Total Debt Issued | -- | -- | -- | 1.23M | 180.00K |
| Total Debt Repaid | -- | -- | -- | -52.00K | -50.00K |
| Issuance of Common Stock | -- | -- | -- | 973.00K | 2.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -204.00K | -93.00K |
| Cash from Financing | -- | -- | -- | 1.94M | 2.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -601.30K | 509.60K |